Alterity Therapeutics Ltd.ASX: ATH

Application for quotation of securities - ATH

Sep 15, 2026 at 10:36 PM EDT · Issued by Alterity Therapeutics Ltd. via ASX

Filed with ASX · Sep 15, 2026 at 10:36 PM EDT

On 6ix: 6ix.com/news/application-for-quotation-of-securities-ath

Appendix 2A - Application for quotation of securitiesAppendix 2A - Application for quotation of securities1 / 8Announcement SummaryEntity nameALTERITY THERAPEUTICS LIMITEDAnnouncement TypeNew announcementDate of this announcementWednesday September 16, 2026The +securities to be quoted are:Total...

View Attachment

6ix hasn’t read this filing yet.

Alterity Therapeutics Ltd. on 6ix

Earlier from Alterity Therapeutics

Cleansing Notice Under Section 708ASep 7
Alterity Therapeutics to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2026Sep 3
Alterity to Present at Cantor Global Healthcare ConferenceSep 2
Change of Director's Interest Notice - StamlerSep 1
Change of Director's Interest Notice - MarksSep 1

Later from Alterity Therapeutics

Alterity Therapeutics to Present at ASX SMIDcaps ConferenceSep 17
Corporate Presentation September 2026Sep 22
Date of AGM and Closing Date for Director NominationsSep 24
Alterity Presents New Analyses of ATH434 Phase 2 Data in MSAOct 4
Alterity Therapeutics Presents New Analyses of ATH434 Phase 2 Data in Multiple System Atrophy at the 2026 International Congress of Parkinson’s Disease and Movement DisordersOct 5

All Alterity Therapeutics news releases

Follow Alterity Therapeutics into a list and get an email when it puts out news.

Follow Alterity Therapeutics